RP
LLY icon

Rowlandmiller & Partners’s Eli Lilly LLY Stock Holding History

Rowlandmiller & Partners’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$18.1M Sell
15,075
-155
-1% -$158K 3.3% 6
2026
Q1 		$14M Sell
15,230
-1,194
-7% -$1.21M 2.84% 8
2025
Q4 		$17.7M Sell
16,424
-973
-6% -$930K 3.41% 6
2025
Q3 		$13.3M Sell
17,397
-1,674
-9% -$1.25M 2.61% 8
2025
Q2 		$14.9M Sell
19,071
-65
-0.3% -$50.5K 3.07% 8
2025
Q1 		$15.8M Sell
19,136
-684
-3% -$569K 3.33% 6
2024
Q4 		$15.3M Sell
19,820
-799
-4% -$662K 3.2% 7
2024
Q3 		$18.3M Sell
20,619
-70
-0.3% -$62.9K 3.71% 4
2024
Q2 		$18.7M Sell
20,689
-1,719
-8% -$1.38M 4.08% 4
2024
Q1 		$17.4M Sell
22,408
-916
-4% -$652K 3.68% 4
2023
Q4 		$13.6M Sell
23,324
-737
-3% -$430K 3.12% 6
2023
Q3 		$12.9M Sell
24,061
-493
-2% -$254K 3.19% 6
2023
Q2 		$11.5M Sell
24,554
-528
-2% -$221K 2.72% 8
2023
Q1 		$8.61M Sell
25,082
-1,508
-6% -$509K 2.09% 15
2022
Q4 		$9.71M Sell
26,590
-1,996
-7% -$708K 2.4% 12
2022
Q3 		$9.24M Sell
28,586
-568
-2% -$180K 2.49% 10
2022
Q2 		$9.45M Sell
29,154
-1,307
-4% -$392K 2.42% 12
2022
Q1 		$8.72M Sell
30,461
-2,560
-8% -$659K 2.02% 14
2021
Q4 		$9.12M Sell
33,021
-5,243
-14% -$1.33M 2.04% 15
2021
Q3 		$6.28M Buy
38,264
+2,158
+6% +$533K 2.13% 13
2021
Q2 		$8.29M Buy
36,106
+18
+0% +$3.62K 2.04% 16
2021
Q1 		$6.74M Sell
36,088
-850
-2% -$166K 1.76% 17
2020
Q4 		$6.24M Sell
36,938
-2,452
-6% -$366K 1.78% 17
2020
Q3 		$5.46M Buy
39,390
+1,126
+3% +$174K 2.19% 12
2020
Q2 		$6.28M Sell
38,264
-1,126
-3% -$173K 2.13% 13
2020
Q1 		$5.46M Buy
39,390
+47
+0.1% +$6.46K 2.19% 12
2019
Q4 		$5.17M Sell
39,343
-100
-0.3% -$11.6K 1.61% 21
2019
Q3 		$4.43M Buy
39,443
+1,424
+4% +$159K 1.5% 22
2019
Q2 		$4.19M Sell
38,019
-101
-0.3% -$11.9K 1.45% 22
2019
Q1 		$4.95M Sell
38,120
-913
-2% -$111K 1.77% 18
2018
Q4 		$4.52M Buy
39,033
+504
+1% +$56.3K 1.83% 19
2018
Q3 		$4.13M Sell
38,529
-719
-2% -$71.9K 1.5% 24
2018
Q2 		$3.36M Sell
39,248
-5,023
-11% -$413K 1.31% 25
2018
Q1 		$3.43M Buy
44,271
+864
+2% +$69.6K 1.36% 23
2017
Q4 		$3.67M Sell
43,407
-417
-1% -$35.5K 1.44% 23
2017
Q3 		$3.73M Sell
43,824
-1,247
-3% -$102K 1.55% 24
2017
Q2 		$3.71M Buy
45,071
+309
+0.7% +$25.2K 1.57% 23
2017
Q1 		$3.77M Sell
44,762
-73
-0.2% -$5.85K 1.66% 22
2016
Q4 		$3.3M Sell
44,835
-666
-1% -$49.6K 1.49% 24
2016
Q3 		$3.65M Buy
45,501
+79
+0.2% +$6.32K 1.69% 20
2016
Q2 		$3.57M Sell
45,422
-40
-0.1% -$3.01K 1.64% 18
2016
Q1 		$3.27M Buy
45,462
+1,160
+3% +$87.8K 1.55% 18
2015
Q4 		$3.68M Sell
44,302
-532
-1% -$44.1K 1.87% 16
2015
Q3 		$3.75M Sell
44,834
-671
-1% -$56.6K 1.98% 16
2015
Q2 		$3.8M Sell
45,505
-1,659
-4% -$126K 1.89% 16
2015
Q1 		$3.37M Sell
47,164
-1,257
-3% -$89.5K 1.68% 19
2014
Q4 		$3.34M Buy
+48,421
New +$3.27M 1.62% 22

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
SC
Sapient Capital Indianapolis, Indiana $7.64B AUM 51.51% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Rowlandmiller & Partners's LLY Position: Q2 2026 in Review

Rowlandmiller & Partners reduced its Eli Lilly (LLY) stake by 1% in Q2 2026, selling an estimated $158K and leaving 15,075 shares worth $18.1M. The position accounts for 3.3% of the portfolio, ranked #6.

Rowlandmiller & Partners first reported a position in LLY in Q4 2014 and has held it in 47 quarters since. The position peaked at $18.7M in Q2 2024. 2,247 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Rowlandmiller & Partners held 15,075 shares of Eli Lilly worth $18.1M as of Q2 2026.
  • Rowlandmiller & Partners sold 155 Eli Lilly shares in Q2 2026, an estimated $158K.
  • Eli Lilly made up 3.3% of Rowlandmiller & Partners's portfolio in Q2 2026, its #6 holding.
  • Rowlandmiller & Partners first reported a position in Eli Lilly in Q4 2014 and has held it in 47 quarters since.
  • Rowlandmiller & Partners's Eli Lilly position peaked at $18.7M in Q2 2024.
  • 2,247 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Rowlandmiller & Partners's 13F filing for Q2 2026, filed 23 Jul 2026.